Stay updated on Psilocybin-Induced Neuroplasticity in MDD Clinical Trial

Sign up to get notified when there's something new on the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the web page.
    Difference
    0.2%
    Check dated 2024-06-13T23:01:36.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update or modification in the context of Medical and healthcare-related publications and documentation.
    Difference
    0.2%
    Check dated 2024-06-06T14:41:00.000Z thumbnail image
  7. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage related to the Estimated Study Completion Date has recently changed from 27 to 28. This change indicates a potential update in the expected completion date of the study on Psilocybin-Induced Neuroplasticity in the Treatment of Major Depressive Disorder.
    Difference
    0.4%
    Check dated 2024-05-30T09:24:30.000Z thumbnail image
  8. Check
    18 days ago
    Change Detected
    Summary
    The value on the webpage has changed from an estimated study completion date of 2023-06-07 to an actual study completion date of 2021-07-08. This change likely indicates that the study has concluded earlier than initially expected.
    Difference
    4%
    Check dated 2024-05-29T07:40:37.000Z thumbnail image
  9. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including specific inclusion and exclusion criteria for those diagnosed with Major Depressive Disorder (MDD). Previously, this section had no information provided.
    Difference
    16%
    Check dated 2024-05-22T21:12:00.000Z thumbnail image
  10. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T21:51:47.000Z thumbnail image

Stay in the know with updates to Psilocybin-Induced Neuroplasticity in MDD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page.